223 related articles for article (PubMed ID: 28423957)
1. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
2. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse drug reactions: an 8-year retrospective study on hospitalized patients in Southern China.
Wang F; Li Y; Mo Y; Shen C; Yang L; Zhang X
Indian J Dermatol Venereol Leprol; 2012; 78(4):488-90. PubMed ID: 22772622
[No Abstract] [Full Text] [Related]
4. Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans.
Yang F; Yang Y; Zhu Q; Chen SA; Fu X; Yan S; Meng C; Ma L; Sun X; Xu J; Luo X; Xing Q
J Investig Dermatol Symp Proc; 2015 Jul; 17(1):29-31. PubMed ID: 26067314
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
[TBL] [Abstract][Full Text] [Related]
7. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of cutaneous adverse drug reactions in Southwest China: an 11-year retrospective survey on in-patients of a dermatology ward.
Zhong H; Zhou Z; Wang H; Niu J; Chen W; Song Z; Hao F
Dermatitis; 2012; 23(2):81-5. PubMed ID: 22653124
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
13. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
14. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia.
Loo CH; Tan WC; Khor YH; Chan LC
Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529
[TBL] [Abstract][Full Text] [Related]
17. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
18. [Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia].
Gamba C; Schroeder J; Citterio A; Cazzaniga S; Rivolta AL; Vighi G;
Recenti Prog Med; 2014 Oct; 105(10):379-84. PubMed ID: 25282350
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous adverse drug reactions in a hospital-based Chinese population.
Huang HY; Luo XQ; Chan LS; Cao ZH; Sun XF; Xu JH
Clin Exp Dermatol; 2011 Mar; 36(2):135-41. PubMed ID: 20738322
[TBL] [Abstract][Full Text] [Related]
20. Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
Tangamornsuksan W; Lohitnavy M
JAMA Dermatol; 2018 Apr; 154(4):441-446. PubMed ID: 29541744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]